Search Within

Sloan Kettering Institute Postdocs

Formats
  1. Journal Article (8036)
  2. Meeting Abstract (3693)
  3. Review (630)
  4. Editorial (262)
  5. Book Section (195)
  6. Conference Paper (161)
  7. Research Letter (139)
  8. Correspondence (68)
  9. Miscellaneous (67)
  10. Guidelines (30)
  11. Book Whole (6)
Groups
  1. GSK Faculty (6363)
  2. Department of Medicine (4809)
  3. Sloan Kettering Institute Faculty (3570)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (3037)
  5. Surgery (2633)
  6. Solid Tumor Oncology Division (2604)

More Groups

People
  1. Britta Weigelt (376)
  2. Jorge Reis-Filho (328)
  3. Mithat Gonen (318)
  4. Marc Ladanyi (309)
  5. Michael Berger (288)
  6. Joseph Deasy (285)

More People

Years
  1. 2026 (1)
  2. 2025 (697)
  3. 2024 (1080)
  4. 2023 (1152)
  5. 2022 (1366)
  6. 2021 (1179)

More Years

Publications
  1. Blood (680)
  2. Cancer Research (543)
  3. Journal of Clinical Oncology (431)
  4. Journal of Nuclear Medicine (271)
  5. Annals of Surgical Oncology (264)
  6. Clinical Cancer Research (249)

More Publications

Publishers
  1. Nature Publishing Group (1349)
  2. Elsevier Inc. (1106)
  3. American Association for Cancer Research (1058)
  4. Springer (840)
  5. American Society of Hematology (740)
  6. Cell Press (740)

More Publishers

Results (13287)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Physician treatment preferences in relapsed/refractory follicular lymphoma: A discrete choice experiment
    Meeting Abstract

    Gribben, J. G.; Bachy, E.; Ray, M.; Krupsky, K.; Beusterien, K.; Kopenhafer, L.; Mendez, F.; Beygi, S.; Best, T.; Ball, G.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • An updated comparison of clinical outcomes from 4-year follow-up of ZUMA-5 (axicabtagene ciloleucel) and the international scholar-5 external control cohort in relapsed/refractory follicular lymphoma
    Meeting Abstract

    Gribben, J. G.; Ghione, P.; Palomba, M. L.; Ray, M. D.; Limbrick-Oldfield, E. H.; Kanters, S.; Bobillo, S.; Ribiero, M. T.; Jacobson, C. A.; Neelapu, S. S.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Antigen-specific t-cell repertoire responses following COVID-19 vaccination are intact in majority of patients with B-cell lymphoid malignancies on active therapy
    Meeting Abstract

    Goel, S.; Griffiths, E. A.; Segal, B.; Nemeth, M.; Cortese, M. J.; Hernandez-Ilizaliturri, F. J.; Banbury, B.; Schumacher, E.; Torka, P.; Ghione, P.
    Blood (2023)

    Fulltext@MSK | Save
  • A pro-inflammatory gene signature characterizes a better risk aged AML patient group in ECOG-ACRIN Cancer Research Group's clinical trial E3999
    Meeting Abstract

    Neelamraju, Y.; Rapaport, F.; Gandara, J. A.; Dunham, N.; Fan, H.; Lee, T.; Prajapati, S.; Sheridan, C.; Wang, L.; Cripe, L. D.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Mutant p53 drives the development of myelodysplastic syndromes via dysregulating pre-mRNA splicing in hematopoietic stem and progenitor cells
    Meeting Abstract

    Barajas, S.; Chen, S.; Vemula, S.; Yang, Y.; Simpson, E.; Cai, W.; Xiao, S.; Chen, H.; Halene, S.; Sukhanova, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • A de novo supernumerary ring chromosome 1 causes B-cell acute lymphoblastic leukemia in monozygotic twins due to independent and partially convergent evolutionary trajectories
    Meeting Abstract

    Gutiérrez-Abril, J.; Gundem, G.; Fiala, E.; Liosis, K.; Farnoud, N.; Leongamornlert, D.; Amallraja, A.; Ossa, J. E. A.; Domenico, D.; Levine, M. F.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Patterns and safety of glucocorticosteroids use following CD19 CAR-T cell therapy for B-cell lymphoma
    Meeting Abstract

    Luttwak, E.; Flynn, J. R.; Devlin, S. M.; Cassanello, G.; Corona, M.; Dahi, P. B.; Luna De Abia, A.; Fein, J.; Giralt, S. A.; Landego, I.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Comparison of bendamustine versus fludarabine/cyclophosphamide lymphodepletion in adult patients receiving CD19 CAR-T cell therapy
    Meeting Abstract

    Landego, I.; Nemirovsky, D.; Devlin, S. M.; Wills, B.; Parascondola, A.; Saldia, A.; Dahi, P. B.; Tomas, A. A.; Ip, A.; Suh, H. C.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • First fever between lymphodepletion and day 30 after CAR-T cell therapy: Patterns, origins, and implications in lymphoma patients
    Meeting Abstract

    Melica, G.; Luna, A.; Fei, T.; Corona, M.; Dahi, P. B.; Fein, J.; Giralt, S. A.; Raj, S.; Landego, I.; Lin, R. J.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • The impact of cardiovascular vulnerabilities in non Hodgkin lymphoma patients treated with chimeric antigen receptor T cell therapy
    Meeting Abstract

    Landego, I.; Flynn, J. R.; Goldman, A.; Devlin, S. M.; Luttwak, E.; Luna De Abia, A.; Corona, M.; Kedmi, M.; Sdayoor, I.; Fried, S.; more...
    Blood (2023)

    Fulltext@MSK | Save